FIORETTO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.641
AS - Asia 4.161
EU - Europa 3.359
AF - Africa 1.215
SA - Sud America 924
OC - Oceania 114
Continente sconosciuto - Info sul continente non disponibili 68
Totale 23.482
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.012
SG - Singapore 1.226
CN - Cina 751
HK - Hong Kong 708
IT - Italia 594
BR - Brasile 564
FI - Finlandia 351
DE - Germania 337
SE - Svezia 194
UA - Ucraina 194
FR - Francia 181
PL - Polonia 170
VN - Vietnam 163
RU - Federazione Russa 156
IN - India 120
GB - Regno Unito 107
NL - Olanda 96
MX - Messico 58
AT - Austria 55
TR - Turchia 55
IQ - Iraq 54
JP - Giappone 52
ES - Italia 51
IE - Irlanda 49
JO - Giordania 49
EC - Ecuador 48
KR - Corea 47
MK - Macedonia 43
NO - Norvegia 43
PE - Perù 43
TH - Thailandia 43
AR - Argentina 42
SK - Slovacchia (Repubblica Slovacca) 42
UZ - Uzbekistan 42
ZA - Sudafrica 42
PH - Filippine 41
TN - Tunisia 41
AO - Angola 40
CW - ???statistics.table.value.countryCode.CW??? 40
LU - Lussemburgo 40
RO - Romania 40
CI - Costa d'Avorio 39
NP - Nepal 39
DK - Danimarca 38
PS - Palestinian Territory 38
PY - Paraguay 38
TJ - Tagikistan 38
UY - Uruguay 38
AM - Armenia 37
BB - Barbados 37
CL - Cile 37
GT - Guatemala 37
PA - Panama 37
TW - Taiwan 37
GA - Gabon 36
KH - Cambogia 36
CO - Colombia 35
EE - Estonia 35
ID - Indonesia 35
MR - Mauritania 35
SN - Senegal 35
AL - Albania 34
AZ - Azerbaigian 34
CG - Congo 34
CM - Camerun 34
CZ - Repubblica Ceca 34
IR - Iran 34
ME - Montenegro 34
RE - Reunion 34
RS - Serbia 34
TT - Trinidad e Tobago 34
YT - Mayotte 34
AD - Andorra 33
BF - Burkina Faso 33
BY - Bielorussia 33
LB - Libano 33
MG - Madagascar 33
SO - Somalia 33
AE - Emirati Arabi Uniti 32
AU - Australia 32
BG - Bulgaria 32
GE - Georgia 32
GN - Guinea 32
KE - Kenya 32
MY - Malesia 32
SI - Slovenia 32
CY - Cipro 31
DJ - Gibuti 31
GF - Guiana Francese 31
GH - Ghana 31
HN - Honduras 31
IL - Israele 31
IS - Islanda 31
KG - Kirghizistan 31
KZ - Kazakistan 31
MA - Marocco 31
PR - Porto Rico 31
SA - Arabia Saudita 31
BE - Belgio 30
CD - Congo 30
Totale 22.021
Salva come PNG Salva come JPEG
Città #
Fairfield 2.102
Woodbridge 1.293
Houston 1.100
Ashburn 1.092
Ann Arbor 862
Cambridge 719
Chandler 702
Seattle 701
Wilmington 695
Singapore 687
Hong Kong 681
Jacksonville 653
Princeton 336
Boardman 309
San Diego 185
Santa Clara 181
Beijing 174
Medford 153
Bytom 143
Padova 126
Helsinki 125
Nanjing 122
Des Moines 109
Roxbury 107
Munich 93
Los Angeles 84
Guangzhou 70
Chicago 68
São Paulo 48
Amman 47
Pune 46
Ho Chi Minh City 45
Dong Ket 44
Milan 40
Dublin 39
Rome 38
Shenyang 38
Tashkent 38
Hebei 36
Libreville 36
Bridgetown 35
Dushanbe 35
Luanda 35
Phnom Penh 35
Abidjan 34
Dakar 34
New York 34
Nuremberg 34
Nouakchott 33
Andorra la Vella 31
Baku 31
Conakry 31
Accra 30
Hanoi 30
Vienna 30
Yerevan 30
Jiaxing 29
Montevideo 29
Panama City 29
Tianjin 29
Willemstad 29
Castries 28
Kigali 28
Managua 28
Minsk 28
Nanchang 28
Norwalk 28
Riga 28
Ulan Bator 28
Antananarivo 27
Hefei 27
Kampala 27
Nairobi 27
Nassau 27
Bamako 26
Kingstown 26
Lima 26
Tallinn 26
Turku 26
Bishkek 25
Buffalo 25
Cayenne 25
Harare 25
Kinshasa 25
Luxembourg 25
Noumea 25
Podgorica 25
Salt Lake City 25
Skopje 25
Mamoudzou 24
Vientiane 24
Brazzaville 23
Djibouti 23
Lusaka 23
Praia 23
Guatemala City 22
Ouagadougou 22
Dar es Salaam 21
Kingston 21
Ljubljana 21
Totale 15.820
Salva come PNG Salva come JPEG
Nome #
Modifications of Resting Energy Expenditure After Sleeve Gastrectomy 261
Expanding the therapy options for diabetic kidney disease 224
Characterization of subcutaneous and omental adipose tissue in patients with obesity and with different degrees of glucose impairment 208
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 199
Incidence and Predictors of Hypoglycemia 1 Year After Laparoscopic Sleeve Gastrectomy 197
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. 195
High-protein diet: a barrier for sodium-glucose co-transporters 2 inhibitors nephroprotective effects? 191
The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience 185
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 179
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 177
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 177
SGLT2 Inhibitors and the Diabetic Kidney 172
Diagnostic pathways of the complex patients: rapid intensive observation in an Acute Medical Unit. 166
Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable 166
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients 161
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin 161
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative 160
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 152
Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes 151
Overall quality of care predicts the variability of key risk factors for complications in type 2 diabetes: An observational, longitudinal retrospective study 151
Mechanisms linking empagliflozin to cardiovascular and renal protection 148
Acute phase markers of inflammation and glomerular structure in type 2 diabetic patients 146
Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. 146
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus 144
Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study 144
Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive type 2 diabetic patients with microalbuminuria: DIAL study. 140
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study 140
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects 139
Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. 139
Bariatric surgery improves atherogenic LDL profile by triglyceride reduction 137
Patterns of renal injury in NIDDM patients with microalbuminuria 135
Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment 135
Ketone bodies increase glomerular filtration rate in normal man and in patients with Type 1 (insulin-dependent) diabetes mellitus 135
SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis 135
Obesity and COVID-19: an Italian snapshot 134
Impaired Response To Angiotensin-ii In Type-1 (insulin-dependent) Diabetes-mellitus - Role of Prostaglandins and Sodium-lithium Countertransport Activity 133
Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. 132
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 132
Apparent treatment resistant hypertension, blood pressure control and the progression of chronic kidney disease in patients with type 2 diabetes 131
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia 131
Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic, and acetic acids. 130
Five-year predictors of insulin initiation in people with type 2 diabetes under real-life conditions 130
Sudden death with massive hemoptysis from aortobronchial fistula 130
Treatment with dapagliflozin increases FGF-21 gene expression and reduces triglycerides content in myocardial tissue of genetically obese mice 129
Biological Variability of Estimated GFR and Albuminuria in CKD 127
Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. 125
The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: A neutral viewpoint. 125
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 125
Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. 124
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes 123
Type I insulin-dependent diabetic patients show an impaired renal hemodynamic response to protein intake. 123
A defect in glycogen synthesis characterizes insulin resistance in hypertensive patients with type 2 diabetes 122
Glucose and ketone body turnover in carnitine-palmitoyl-transferase deficiency. 121
Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients 120
The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice 120
Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies 119
Impaired renal response to a meat meal in insulin-dependent diabetes: role of glucagon and prostaglandins. 118
Atherogenic dyslipidemia and diabetic nephropathy 118
Renal protection in diabetes: role of glycemic control. 116
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. 115
Residual macrovascular risk in 2013: what have we learned? 115
Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria 115
Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis 115
Predictors of chronic kidney disease in type 1 diabetes: A longitudinal study from the AMD Annals initiative 114
Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure 112
Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism. 112
Histopathology of diabetic nephropathy. 112
Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes 112
The kidney in type 2 diabetes: focus on renal structure. 112
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 112
Antihypertensive treatment and multifactorial approach for renal protection in diabetes 111
The effect of dapagliflozin on renal function in patients with type 2 diabetes 111
Diabetic Nephropathy 109
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 109
Renal structure in type 2 diabetes 108
Porcine and human insulin absorption from subcutaneous tissues in normal and insulin dependent diabetic subjects: a deconvolution-based approach 108
Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. 108
Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance 107
Ketone body metabolism: a physiological and clinical overview. 107
Relationships Among Natriuresis, Atrial-natriuretic-peptide and Insulin In Insulin-dependent Diabetes 107
In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study 107
Reversal of diabetic nephropathy: lessons from pancreas transplantation. 106
Role of Atrial-natriuretic-peptide In the Pathogenesis of Sodium Retention In Iddm With and Without Glomerular Hyperfiltration 106
Vascular endothelial growth factor expression in microdissected glomeruli of type 2 diabetic patients. 105
The kidney in diabetes: dynamic pathways of injury and repair. 105
Tubular Na+ handling in type I insulin-dependent diabetics during saline and ketone body infusion 104
Mesangial expansion in diabetic nephropathy: functional and genetic considerations. 104
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. 104
Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. 103
Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. 102
Ultrastructural measures of glomerular extracellular matrix accumulation in non-proteinuric type 2 diabetic patients. 102
Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference 102
Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: The AMD annals initiative 102
Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. 102
Renal structure incaucasian noninsulindependent diabetic patients. 101
PC-1 aminoacid variant Q121 is associates with lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rate. 101
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. 101
Long-term blood pressure variability, incidence of hypertension and changes in renal function in type 2 diabetes 101
Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients. 100
Is diabetic nephropathy reversible? 100
Totale 13.123
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.783
article - articoli 69.891
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.423
Totale 148.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.936 0 0 0 284 153 162 75 201 343 176 285 257
2021/20222.431 98 283 253 193 145 120 104 263 126 68 245 533
2022/20231.622 453 136 20 142 304 204 2 111 170 12 52 16
2023/2024971 32 118 78 72 69 138 74 45 18 56 138 133
2024/20254.133 27 362 182 171 520 104 265 289 398 204 622 989
2025/20265.728 586 1.442 2.429 1.271 0 0 0 0 0 0 0 0
Totale 23.672